$26.40
Price
$1.3B
Market Cap
—
P/E Ratio
-7.7
Forward P/E
$-2.27
EPS (TTM)
—
Dividend Yield
$513M
Cash
$1M
Total Debt
48M
Shares Out
$6.43
$42.27
52-Week Range
Institutional Ownership of Rapport Therapeutics, Inc.
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| No funds currently hold this stock. | |||||
Trading Activity for Rapport Therapeutics, Inc.
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| No activity found for this stock. | |||||
Insider Trading for Rapport Therapeutics, Inc.
No Insider Transactions
No Form 4 filings found for this stock in the last 2 years.